Array Biopharma Inc.
13F holders, Q3 2025 (September 30)1holders
1new positions
0sold out
$8.15avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Array Biopharma Inc. in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 0 sold out. The largest holder was Byrne Asset Management LLC ($4K).
- Company
- Array Biopharma Inc.
- Filed as
- ARRAY TECHNOLOGIES INC (Q3 2025)
- CUSIP
- 04269X105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 500 shares bought, net +500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Byrne Asset Management LLC | 0.00% | New | 500 | $4K |
"% of holder's portfolio" is ARRAY BIOPHARMA INC's weight in each manager's 13F, not the share of Array Biopharma Inc. the manager owns.